Page 7 - Julie Silber News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Alligator Bioscience AB: Interim report January-September 2021

/PRNewswire/ First Patient Dosed in Optimize-1 Phase II "We continued to make great strides in the third quarter of 2021. The first patient was dosed in.

United kingdomJulie silberMarie svenssonAptevo therapeutics incShanghai henlius biotech incMacrogenics incOrion corporationBiotheus incPatient dosedSenior directorInvestor relationsWall streetScandion oncologyHenlius biotechAlligator bioscienceAptevo therapeutics

Notice of extraordinary general meeting in Alligator Bioscience AB

/PRNewswire/ The shareholders of Alligator Bioscience AB, Reg. No. 556597-8201 ("Alligator"), are invited to the extraordinary general meeting to be held on.

Ola grahnJulie silberMaria pia bengtssonGreta eklundAptevo therapeutics incArticles of associationBiotherus incMacrogenics incSwedish companies registration office swSwedish companies registration officeShanghai henlius biotech incSwedish companies act swSwedish companies registration office or euroclear swedenAlligator bioscienceEuroclear swedenMedicon village

Alligator is exploring financing alternatives to support phase II studies for Mitazalimab, phase II preparations for ATOR-1017 as well as the development of other pipeline

Alligator is exploring financing alternatives to support phase II studies for Mitazalimab, phase II preparations for ATOR-1017 as well as the development of other pipeline
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Julie silberAptevo therapeutics incShanghai henlius biotech incMacrogenics incBiotheus incAlligator bioscienceAptevo therapeuticsShanghai henlius biotechNasdaq stockholm

Alligator Bioscience: Alligator is exploring financing alternatives to support phase II studies for Mitazalimab, phase II preparations for ATOR-1017 as well as the development of other pipeline

Alligator Bioscience: Alligator is exploring financing alternatives to support phase II studies for Mitazalimab, phase II preparations for ATOR-1017 as well as the development of other pipeline
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Julie silberAptevo therapeutics incShanghai henlius biotech incMacrogenics incBiotheus incAlligator bioscienceAptevo therapeuticsShanghai henlius biotechNasdaq stockholm

Herantis Pharma: Results for the First Half Year January 1 - June 30, 2021

Herantis Pharma Plc Company Release August 26, 2021, at 9:00 a.m. EEST/8:00 a.m. CEST Dr. Craig Cook CEO of Herantis commented: In 2021, Herantis continued to optimize its assets and shape the. | August 27, 2021

Hilde furbergGenzyme sanofiJulie silberGabriela urquillaCraig cookHerantis pharmaUb securities ltdNanoform finland plcInternational conference on alzheimerHerantis pharma plcPharma plcReport liveMolecular therapyIn man clinical trialBreast cancer related lymphedemaEuropean head